Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal JunctionJin Li, Hao Yu, Yuxian Bai et al.|Journal of Clinical Oncology|2016Cited by 1k
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trialHongru Yang, Jingbo Wu, Xin Chen et al.|Radiotherapy and Oncology|2017Cited by 104
<p>Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance</p>Shuya Liu, Jingbo Wu, Saber İmani et al.|OncoTargets and Therapy|2020Cited by 46
<i>In vivo</i> antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinomaFang Xie, Qinglian Wen, Ruilin Ding et al.|Drug Delivery|2017Cited by 37
Preparation of endostatin-loaded chitosan nanoparticles and evaluation of the antitumor effect of such nanoparticles on the Lewis lung cancer modelRuilin Ding, Qinglian Wen, Fang Xie et al.|Drug Delivery|2017Cited by 37